NuCana Plc
(NASDAQ) NCNA
NuCana Plc Financials at a Glance
Market Cap
$5.58MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
£0.00
Net Income (TTM)
-£30.75M
EPS (TTM)
-$33.32
P/E Ratio
-0.04
Dividend
$0.00
Beta (Volatility)
1.08 (Average)
Dividend
$0.00
Beta (Volatility)
1.08 (Average)
Price
$1.34
Volume
98,220.43
Open
$1.23
Price
$1.34
Volume
98,220.43
Open
$1.23
Previous Close
$1.34
Daily Range
$1.23 - $1.49
52-Week Range
$1.21 - $13.00
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
1.08 (Average)
Price
$1.34
Volume
98,220.43
Open
$1.23
Previous Close
$1.34
Daily Range
$1.23 - $1.49
52-Week Range
$1.21 - $13.00
Estimated Earnings Date
Aug 13, 2026
NCNA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NuCana Plc
Industry
Biotechnology
Sector
Health CareEmployees
12
CEO
Hugh Stephen Griffith, MBA
Website
www.nucana.comHeadquarters
Edinburgh, MD EH12 9DT, GB
NCNA Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-153.80%
Return on Capital
-80.43%
Return on Assets
-111.58%
Earnings Yield
-25.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.58MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
4.16M
Volume
98.22K
Avg. Volume
47.70K
Financials (TTM)
Gross Profit
£0.00
Operating Income
-£21.68M
EBITDA
-£22.55M
Operating Cash Flow
-£7.54M
Capital Expenditure
-£231.00K
Free Cash Flow
-£7.77M
Cash & ST Invst.
£21.53M
Total Debt
£680.03K
NuCana Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
£0.00
N/A
Gross Profit
£0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$5.58MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$278.85K
N/A
Employees
20
N/A
Net Income
-£3.87M
-56.3%
EBITDA
-£4.71M
-73.0%
Quarterly Fundamentals
Total Cash
£21.53M
+444.7%
Total Debt
£680.03K
+293.1%
Accounts Receivable
£2.17M
-58.0%
Inventory
£0.00
N/A
Long Term Debt
£647.03K
+553.6%
Short Term Debt
£33.00K
-55.4%
Return on Assets
-1.12%
N/A
Return on Invested Capital
-93.95%
N/A
Free Cash Flow
-£3.26M
-3.5%
Operating Cash Flow
-£3.18M
-2.3%